|
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant (Sarah Schillie, MD1; Aaron Harris, MD1; Ruth Link-Gelles, PhD1; José Romero, MD2; John Ward, MD1; Noele Nelson, MD1) |
 |
 |
 Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant Author : Sarah Schillie, MD1; Aaron Harris, MD1; Ruth Link-Gelles, PhD1; José Romero, MD2; John Ward, MD1; Noele Nelson, MD1 Source : Morbidity and Mortality Weekly Report, April 20, 2018 / Vol. 67 / No. 15 |
|
Read more...
|
The hepatitis B virus can cause an acute (lasting less than 6 months) or chronic (lifetime) infection. Chronic infection occurs in 90% of infants infected through mother-to-child transmission at birth; and about 50% of children will develop a chronic infection if exposed to the virus between 1 and 5 years of age. Those infected as adults are much less likely (<5%) to develop a chronic infection. Left untreated, hepatitis B can progress to cirrhosis and other serious liver diseases like liver cancer. This blog will talk about mother-to-child (perinatal) transmission and commonly asked questions about perinatal transmission. 
